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Prior experience with drug treatment
markedly attenuates the formation of
conditioned taste aversions in rats (9).
Our results are interesting in that most of
the patients in this study had received
many prior treatments that caused GI
discomfort (the average number per
child was 23). Furthermore, most of the
patients were aware that the cause of
their nausea and vomiting was their therapy. These factors, however, did not
preclude the formation of long-lasting
taste aversions, suggesting that humans
have a strong propensity to form these
aversions.
Further data were obtained through
the use of questionnaires, the results of
which support and extend these findings.
Patients completed diet inventory forms
during sessions 1 and 2 to provide information about their food preferences and
usual diet, as well as specific foods eaten
before drug treatments. These data (10)
revealed that patients receiving GI toxic
chemotherapy were significantly more
likely to report avoiding or disliking a
specific food eaten before a clinic visit
than control (group 3) patients. Thus,
learned taste aversions may occur not
only to a novel food presented by the experimenter just prior to drug administration, but also to foods in the patients'
diets which happen to be eaten up to several hours before treatment. This is consistent with the findings of Garb and
Stunkard (I) that human subjects report
the development of aversions to a wide
variety of foods consumed coincidentally before a bout of illness.
The demonstration of taste aversions
in children receiving chemotherapy
treatments may prove to be of importance to physicians who administer treatments which induce nausea and vomiting. Such aversions may be one of the
factors contributing to the anorexia and
weight loss seen in patients with cancer.
Additional work is needed to delineate
the factors controlling the occurrence of
these aversions in order to develop
methods for minimizing or eliminating
them.
ILENE L. BERNSTEIN

Department of Psychology,
University of Washington, and
Children's Orthopedic Hospital and
Medical Center, Seattle 98195
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GeneticMethodfor the PreferentialEliminationof
Females of Anopheles albimanus
Abstract. Recent field experiments demonstrated the possibility of using the sterile
male method for the control of Anopheles albimanus Wiedemann, the most important vector of human malaria in Central America. Until now there was no practical
method for excluding females from the releases of sterile males. A genetic method
was developed for the preferential elimination of females during any of the four life
stages. This genetic sexing system utilizes propoxur (o-isopropoxyphenyl methylcarbamate) susceptibility as a recessive conditional lethal, a T(Y:2R) translocation,
and an In(2R) inversion. The propoxur resistance allele (dominant) was linked to the
Y chromosome via a radiation-induced translocation, and genetic recombination
was suppressed by inversions. In one of the strains produced, 99.7 percent of the
females are eliminated when treated with propoxur, without male loss.
During an experiment conducted in El
Salvador, Lofgren et al. (1) demonstrated the possibility of using the sterile
male method for the control of Anopheles albimanus, an important vector of
human malaria in Central America. In
view of the widespread occurrence of insecticide resistance in this species, the
development of this alternate control
method is most desirable and appropriate at this time. The success of the sterile
male method relies on the efficient distribution of inundative releases of competitive, sterile males into the natural
habitat of the target species. Therefore, a
sound system must be available for the
mass production of sterile males, but
since the females of anopheline species
are potential malaria vectors, they
should be excluded from the releases.
Also, if the females could be eliminated
during the egg or early larval stages, the
mass production of males could be conducted less expensively.

Since currently available methods for
elimination of A. albimanus females in a
mass production process are only 85 to
95 percent effective (unpublished data),
we undertook the development of a genetic method for the preferential killing
of females. We now describe the synthesis of a female-killing system for use
in a mass production facility.
The genetic sexing scheme utilizes
propoxur (o-isopropoxyphenyl methylcarbamate) susceptibility (prs) as a recessive conditional lethal, a T(Y: 2R) translocation, and an In(2R) inversion. The
locus for propoxur resistance (prr), a
dominant trait, is on the right arm of
chromosome 2, and this allele was linked
to the Y chromosome via a radiation-induced translocation. Adult homozygous
resistant males (prr/prr), less than 24
hours old, were irradiated with 1700 R
(dose rate 212 R/min) from an x-ray machine operated at 90 kV (peak). These irradiated males were crossed to suscep-
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Table 1. Results of rearingT(Y:2R) translocationstrains treated as larvae with 20 parts of
propoxurper million(datacollected over five generations).
S

Strain

Number

Sterility
yof
34
52
48
49
52
57

T(Y:2R)2
T(Y:2R)3
T(Y:2R)4
T(Y:2R)5
T(Y:2R)6
T(Y:2R)7

males

Number
of
females

Percent
crossing
over

425
759
1471
2669
793
762

127
276
130
176
190
142

23
27
8
6
19
16

Table 2. Results of rearingT(Y:2R)translocation-In(2R)inversion strains treated with propoxur.
Strain
In(2R)[T(Y:2R)3]1
In(2R)[T(Y:2R)3]2
ln(2R)[T(Y:2R)6]1
In(2R)[T(Y:2R)4:T(2R:3R)]l

Sterit
iy
56
46
49
65

tible females (prs/pr5), and the resultant
F, males were backcrossed to susceptible females. The backcross progeny
from families that showed less than 60
percent egg hatch were single-family cultured (2) and treated in the larval stage
with an exposure (30 minutes in 20 parts
of propoxur per million) that killed the
homozygotes (pr/prS), but not the het(prs/prr). Discriminating
erozygotes
treatments are available for separating
the two genotypes during the egg, larval,
pupal, or adult stages (unpublished
data). If an appropriate translocation
were present in an F1 male, then a distortion in sex ratio would be evident
among his progeny. Chromosomal aberrations detected in this manner were
confirmed by examination of salivary
gland chromosomes with an established
technique (3). A total of 1200 sperm were
tested, and six T(Y:2R) translocations
were isolated (Table 1).
Since genetic recombination occurs in
both sexes of A. albimanus, some heterozygous resistant females (prr/prs)are
produced each generation. For the
stocks we studied, the recombination
frequencies ranged from 0.06 to 0.27.
The male-linked translocations proved to
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Number
of
males

Number
of
females

Percent
crossing
over

2372
2945
1975
807

55
6
41
17

2.3
0.20
2.0
2.1

be holandric, a fact strongly suggesting
that the crossing over is restricted to the
autosome.
To suppress the incidence of recombination, we irradiated males of these
translocation stocks to induce an inversion. Several inversions were isolated, and the strains showing the least
number of recombinant, resistant females are shown in Table 2. For clarification, the strain designation In(2R)[T(Y: 2R)312 identifies the second inversion induced from the T(Y:2R)3
translocation strain. The inversion covers part of the Y-2R chromosome that resulted from the original irradiation and
includes the centromere of the Y
chromosome.
Of the four strains shown in Table 2,
In(2R)[T(Y: 2R)3]2 is the most appropriate for the purpose of a mass production
system because it has the maximum level
of fertility (54 percent) and the minimum
recombination frequency (0.0016). It is
of interest to note that the original
T(Y: 2R)3 strain usually produces 27 percent recombinant females.
In(2R)[T(Y: 2R)3]2 has been mass cultured for several generations and has
proved to be quite suitable for that type

of production. Exposure of this strain to
propoxur eliminates 99.7 percent of the
females. This elimination can be done in
the egg stage or in subsequent stages of
the life cycle, depending upon the need.
Furthermore, since three pairs of
chromosomes are found in this species it
is a relatively simple matter to incorporate wild genome into the strain.
The genetic sexing system described
herein is similar to those developed for
Lucilia cuprina (4) and Anopheles gambiae (5). A "male-producing" strain was
also developed in Musca domestica (6)
by using a temperature-sensitive lethal
and a male-determining autosome.
For those species of insect pests that
can be controlled by the release of sterile
males, the use of a genetic sexing system
can be of great benefit, especially in the
curtailment of rearing costs. However,
cost is not the only consideration. The
sterile male method has been considered
unsuitable for some species where sexual separation is difficult because the females cause extensive damage or are potential disease vectors. In some cases,
the treatment used to sterilize males is
ineffective on the females. The development and implementation of genetic sexing systems could possibly increase the
number of species for which the sterile
male method can be used.
J. A. SEAWRIGHT
P. E. KAISER
D. A. DAME,C. S. LOFGREN
Insects Affecting Man and Animals
Research Laboratory, U.S. Department
ofAgriculture, P.O. Box 14565,
Gainesville, Florida 32604
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